Unicycive Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell UNCY and other ETFs, options, and stocks.About UNCY
Unicycive Therapeutics, Inc. engages in the development of treatment for kidney diseases. Its products include UNI-494, Renazorb, and UNI-220.
CEOShalabh Gupta
CEOShalabh Gupta
Employees22
Employees22
HeadquartersLos Altos, California
HeadquartersLos Altos, California
Founded2016
Founded2016
Employees22
Employees22
UNCY Key Statistics
Market cap133.89M
Market cap133.89M
Price-Earnings ratio-1.92
Price-Earnings ratio-1.92
Dividend yield—
Dividend yield—
Average volume363.13K
Average volume363.13K
High today$6.57
High today$6.57
Low today$6.20
Low today$6.20
Open price$6.41
Open price$6.41
Volume249.79K
Volume249.79K
52 Week high$11.00
52 Week high$11.00
52 Week low$3.71
52 Week low$3.71
Stock Snapshot
The current Unicycive Therapeutics(UNCY) stock price is $6.34, with a market capitalization of 133.89M. The stock trades at a price-to-earnings (P/E) ratio of -1.92.
On 2025-12-14, Unicycive Therapeutics(UNCY) stock traded between a low of $6.20 and a high of $6.57. Shares are currently priced at $6.34, which is +2.3% above the low and -3.5% below the high.
The Unicycive Therapeutics(UNCY)'s current trading volume is 249.79K, compared to an average daily volume of 363.13K.
During the past year, Unicycive Therapeutics(UNCY) stock moved between $3.71 at its lowest and $11.00 at its peak.
During the past year, Unicycive Therapeutics(UNCY) stock moved between $3.71 at its lowest and $11.00 at its peak.
Analyst ratings
100%
of 8 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own UNCY. This list is generated using Robinhood data, and it’s not a recommendation.